Fore Biotherapeutics

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Overview Structured Data Issues Contributors

fore.bio

Is a

Organization

Company

Company attributes

Industry

Genetics

Biotechnology

Pharmaceutical industry

Health technology

Location

Philadelphia County, Pennsylvania

B2X

CEO

Founder

Number of Employees (Ranges)

11 – 50

Email Address

trials@fore.bio

Phone Number

+12676417575

Investors

Windham Venture Partners

SR One

Helsinn

‌

Bio Capital Impact Fund

Total Funding Amount (USD)

43,400,000

Latest Funding Round Date

May 15, 2025

CFO

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

37,400,000

Previous Name

NovellusDx

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Fore Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.